Triton Pacific Healthcare Partners sells BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners
Triton Pacific Healthcare Partners, a notable healthcare-focused private equity group, has successfully concluded the sale of BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners. While ... Read More
Kohlberg, Mubadala to acquire majority stake in PCI Pharma Services
Kohlberg & Company and Mubadala Investment have agreed to acquire a majority stake in drug development solutions provider PCI Pharma Services, a portfolio company of ... Read More
Frazier Healthcare Partners raises $617m for life sciences fund
Frazier Healthcare Partners has closed its third life sciences fund - Frazier Life Sciences X, at more than $617 million in capital commitments. The Seattle-based private equity ... Read More